MARKSANS PHARMA
Back to Income Statement
|
MARKSANS PHARMA Last 5 Year Operating Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹533 Cr | ₹459 Cr | ₹339 Cr | ₹259 Cr | ₹340 Cr |
What is the latest Operating Profit of MARKSANS PHARMA ?
| Year | Operating Profit |
|---|---|
| Mar2026 | ₹533 Cr |
| Mar2025 | ₹459 Cr |
| Mar2024 | ₹339 Cr |
| Mar2023 | ₹259 Cr |
| Mar2022 | ₹340 Cr |
How is Operating Profit of MARKSANS PHARMA Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹533 Cr | 16.16 | |
| Mar2025 | ₹459 Cr | 35.15 | |
| Mar2024 | ₹339 Cr | 31.07 | |
| Mar2023 | ₹259 Cr | -23.77 | |
| Mar2022 | ₹340 Cr | - | |
Compare Operating Profit of peers of MARKSANS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MARKSANS PHARMA | ₹14,158.0 Cr | 4.2% | -3.1% | 72.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹424,202.0 Cr | 0.5% | -2.9% | 5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹264,141.0 Cr | 5% | 7.2% | 49.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹174,402.0 Cr | -0.5% | -4.5% | 28.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,868.0 Cr | 2.7% | 8.4% | 5.1% | Stock Analytics | |
| CIPLA | ₹111,650.0 Cr | 2.4% | 2.4% | -12.9% | Stock Analytics | |
MARKSANS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MARKSANS PHARMA | 4.2% |
-3.1% |
72.3% |
| SENSEX | 2.8% |
4.4% |
-10.1% |
You may also like the below Video Courses